• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The suppression of factor VIII antibodies in haemophilia.

作者信息

Dormandy K M, Sultan Y

出版信息

Pathol Biol (Paris). 1975 Dec;23 suppl:17-23.

PMID:772555
Abstract

Three severely affected haemophiliacs who had developed antibodies to factor VIII are described in whom the administration of cyclophosphamide was thought to have prevented reappearance of the antibody after factor VIII infusion. Some of the possible causes which might have led to the favourable outcome in these and three other, previously reported, patients in whom the antibody, which was raised at the time of IS therapy, dropped to zero and failed to reappear, are discussed. It is suggested that immunosuppressive therapy was effective in these patients as it was given during or soon after the primary immune response. As the antibody response becomes increasingly well established, so the chances of successful immunosuppressive therapy recede.

摘要

相似文献

1
The suppression of factor VIII antibodies in haemophilia.
Pathol Biol (Paris). 1975 Dec;23 suppl:17-23.
2
Management of haemophilia A with antibodies--the effect of combined treatment with factor VIII, hydrocortisone and cyclophosphamide.
Thromb Haemost. 1985 Dec 17;54(4):776-9.
3
[Treatment of patients with hemophilia A having antibodies to factor VIII].[对患有抗凝血因子VIII抗体的甲型血友病患者的治疗]
Acta Haematol Pol. 1979 Apr-Jun;10(2):115-22.
4
[Preliminary experience with achieving immune tolerance in patients with hemophilia A and circulating factor VIII inhibitor].
Acta Haematol Pol. 1991;22(1):92-9.
5
Disappearance of factor VIII antibodies upon frequent administration of factor VIII.频繁给予凝血因子 VIII 后凝血因子 VIII 抗体消失
Folia Haematol Int Mag Klin Morphol Blutforsch. 1990;117(4):533-7.
6
Mechanisms of action of immune tolerance induction against factor VIII in patients with congenital haemophilia A and factor VIII inhibitors.先天性A型血友病患者及VIII因子抑制物患者中诱导针对VIII因子的免疫耐受的作用机制。
Br J Haematol. 2007 Jan;136(1):12-25. doi: 10.1111/j.1365-2141.2006.06359.x.
7
New protocol for immune tolerance induction in acquired hemophilia.获得性血友病免疫耐受诱导的新方案。
Haematologica. 2000 Oct;85(10 Suppl):64-8.
8
Induction of immune tolerance in patients with hemophilia and antibodies to factor VIII by combined treatment with intravenous IgG, cyclophosphamide, and factor VIII.
N Engl J Med. 1988 Apr 14;318(15):947-50. doi: 10.1056/NEJM198804143181503.
9
[Long-term response to rituximab in a patient with acquired hemophilia].[利妥昔单抗对一名获得性血友病患者的长期疗效]
Rev Invest Clin. 2011 Mar-Apr;63(2):210-2.
10
Suppression of factor VIII antibody by combined factor VIII and cyclophosphamide.
Acta Med Scand. 1974 Jan-Feb;195(1-2):64-72.

引用本文的文献

1
Clinical Care of Bone Health in Patients on the Immune Tolerance Induction's Protocols With an Immunosuppressive Agent for Inhibitor Eradication in Hemophilia.血友病患者接受免疫耐受诱导方案联合免疫抑制剂以消除抑制剂的临床骨健康护理。
Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620913951. doi: 10.1177/1076029620913951.